Numinus Wellness (CVE:NUMI) is analysed by Ed Stacey from Proactive Research with Katie Pilbeam.
Stacey begins by stating how the company is arguably 'three to five years ahead of many peers in terms of maturity model'. Numinus is a life sciences company with a focus on mental health and wellness.
The company is engaged in research, development and delivery of safe, evidence-based psychedelic-assisted psychotherapy.